Genomma Lab Internacional, S.A.B. de C.V. GNMLF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 28.01% | 18.39% | 15.25% | 309.65% | -33.24% |
| Total Depreciation and Amortization | 1.72% | 10.19% | 8.64% | -14.20% | 9.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | 72.34% | -- |
| Total Other Non-Cash Items | 471.06% | 37.76% | 83.12% | -60.72% | -64.95% |
| Change in Net Operating Assets | -197.76% | -116.83% | -36.19% | 32.51% | -125.96% |
| Cash from Operations | 21.45% | -15.62% | -76.33% | 7.21% | -69.45% |
| Capital Expenditure | 79.54% | -55.78% | -26.37% | -47.06% | -222.25% |
| Sale of Property, Plant, and Equipment | -21,467.19% | 1,874.50% | -- | -8.53% | -93.90% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 178.42% | 983.46% | 139.74% | -148.98% | 91.86% |
| Cash from Investing | 82.01% | 138.41% | 25.81% | -670.71% | 69.10% |
| Total Debt Issued | 108.80% | -73.77% | 39.52% | -13.11% | -8.82% |
| Total Debt Repaid | -120.13% | 55.74% | -100.27% | 51.84% | 13.15% |
| Issuance of Common Stock | -- | -- | -- | 9.11% | -- |
| Repurchase of Common Stock | 23.28% | -- | 52.50% | -9.86% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 46.27% | -- | -16.16% | -16.99% | -102.88% |
| Other Financing Activities | 32.11% | 10.45% | 20.30% | 27.67% | 18.02% |
| Cash from Financing | 66.06% | -636.90% | 218.67% | 65.94% | -47.85% |
| Foreign Exchange rate Adjustments | 102.93% | 133.75% | -252.80% | -389.03% | -252.42% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 239.96% | -157.26% | -30.56% | 3.22% | -140.83% |